VitamFero : The French biotech with a €1bn pipeline - Animal Pharm

admin.vitamfero's picture

Established in 2005, VitamFero expects its first anti-infective vaccines for food-producing animals to be launched in 2017. The company's debut vaccine – currently under development – will be for ovine toxoplasmosis. The firm hopes to out-license its products to a partner who can take the vaccine through full clinical development.

Type de page: 
Ils parlent de nous